glp 1 agonist alcohol Could GLP-1 receptor agonists represent a new frontier in the treatment of use disorder? Join "Injecting Hope: GLP-1 Receptor Agonists for the Treatment of Alcohol Use Disorder" to explore the latest GLP-1 receptor agonists may protect

Pemvidutide, a GLP-1/glucagon dual receptor agonist, significantly reduces liver fat, fibro-inflammation, and body weight in patients with non-alcoholic fatty liver disease: a 24-week multicenter, randomized, double-blind, placebo-controlled trial

The outcomes of these trials, both the verdicts and the reasoning behind them, inform settlement negotiations for the remaining thousands of cases

That changes how clinicians manage patients in real time

Weight fluctuations

At a time when more people are prioritizing whole-body wellness, Pendulum is helping consumers go beyond traditional probiotics

The transient receptor potential channel TRPA1: from gene to pathophysiology